v3.26.1
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net loss $ (5,790) $ (6,532)
Add items not affecting cash    
Share-based compensation 2,961 3,286
Deferred income tax benefit (2,388) (873)
Foreign exchange (gain) loss (4,719) 735
Investment loss from Smackover Lithium 2,980 2,244
Fair value gain on Investment in Aqualung (204) (2,752)
Fair value loss (gain) on financial asset - FID 644 (3,283)
Amortization 248 648
Interest expense 9 18
Other 13 12
Net changes in non-cash working capital items:    
Other current assets and receivables (743) (1,612)
Accounts payable and accrued liabilities (2,013) 1,069
Net cash used in operating activities (9,002) (7,040)
Investing activities    
Smackover Lithium capital contributions (27,225) (8,250)
Exploration and evaluation assets   (6)
Purchase of property, plant and equipment (4)  
Change in restricted cash (16) 59
Patents   (42)
Net cash used in investing activities (27,245) (8,239)
Financing activities    
Proceeds from at-the-market equity program ("ATM") 20,183 18,484
Exercise of Options 1,839  
Share issuance costs (584) (447)
Lease payments (94) (178)
Net cash provided by financing activities 21,344 17,859
Effect of exchange rates on cash (160) 30
Net change in cash (15,063) 2,610
Cash, beginning of period 152,314 31,177
Cash, end of period 137,251 $ 33,787
Non-cash investing and financing    
Change in proceeds from issuance of shares included in accounts receivable 1,900  
Change in share issuance costs included in accounts payable $ 134